Results 81 to 90 of about 23,386 (218)
International Journal of Cancer, Volume 158, Issue 9, Page 2418-2428, 1 May 2026.What's new? Cavity carcinomatosis, a late manifestation of cancer, fuels tumor formation throughout a large area, most commonly the peritoneal and pleural cavities. The condition also can lead to resistance to otherwise effective treatment strategies.
Zhongqiao Lin +6 more
wiley +1 more source
European Radiology Experimental, 2022 The detection of peritoneal carcinomatosis in patients with ovarian cancer is crucial to establish the correct therapeutic planning (debulking surgery versus neoadjuvant chemotherapy).
Giada Zorzetto +9 more
doaj +1 more source
Veterinary Record Case Reports, Volume 14, Issue 2, May 2026.Abstract This case report describes an atypical presentation of a canine urothelial cell carcinoma and its outcome. An 11‐year‐old, male, entire Jack Russell dog was presented with a history of dysuria unresponsive to medical management. An abdominal ultrasound revealed an atypical mural mass‐like lesion, with no evidence of mucosal involvement and ...
Maria Teresa Pinto +5 more
wiley +1 more source
, 2019 Recent advances in locoregional chemotherapy have opened the door to new approaches for the clinical management of peritoneal carcinomatosis (PC) by facilitating the delivery of anti-neoplastic agents directly to the tumor site, while mitigating adverse ...
Ceelen, Wim +4 more
core +1 more source
Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study. [PDF]
, 2017 Background. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has been introduced as a novel repeatable treatment for peritoneal carcinomatosis.
Demartines, N. +6 more
core +3 more sources
Peritoneal carcinomatosis mimicking a peritoneal tuberculosis
Obstetrics & Gynecology Science, 2015 Symptoms of a peritoneal progression from ovarian cancer are nonspecific such as abdominal pain, abdominal distention and more. Many imaging studies and serum CA-125 help diagnosis. However, it is difficult to exclude the instances of the diffuse peritoneal diseases that mimic carcinomatosis.
Jung, Eun Young +5 more
openaire +2 more sources
International Journal of Cancer, Volume 158, Issue 8, Page 2043-2050, 15 April 2026.What's New? High‐grade serous ovarian carcinoma is often diagnosed at advanced stages due to non‐specific symptoms and the lack of reliable screening methods. This proof‐of‐concept study introduces a novel TP53 mutation panel using unique molecular identifier‐based next‐generation sequencing for sensitive detection of high‐grade serous ovarian ...
Amanda Olsson Widjaja +11 more
wiley +1 more source
Intestinal obstruction due to malign breast neoplasm and peritoneal carcinomatosis: a case report
Journal of Coloproctology, 2012 Peritoneal carcinomatosis due to breast cancer is rare and gastrointestinal tract involvement is also unusual. Symptoms are unspecific and can begin many years after the primary tumor.
Flávia Balsamo +3 more
doaj +1 more source
Role of galectin-3 combined with multi-detector contrast enhanced computed tomography in predicting disease recurrence in patients with ovarian cancer [PDF]
, 2017 Galectin-3 (Gal-3) is an endogenous β-galactoside-binding lectin, playing an important role in the pathogenesis of multiple malignancies. Aim of the study was to evaluate in a group of patients treated for ovarian cancer (EOC), the role of Gal-3 ...
ANASTASI, Emanuela +9 more
core +1 more source
Advanced Therapeutics, Volume 9, Issue 4, April 2026.Advanced ovarian cancer has a poor prognosis largely due to chemoresistance driven by ATP‐binding cassette (ABC) drug efflux transporters, especially P‐glycoprotein (P‐gp, or ABCB1). While photodynamic therapy (PDT) with FDA‐approved benzoporphyrin derivative (BPD) can inhibit ABC transporters, BPD alone lacks cancer selectivity.
Kathryn L. McNaughton +6 more
wiley +1 more source